Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

Lucknow: New medical techniques can prove helpful in the treatment of Parkinson's disease, said experts at the ISBC ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...

Jan. 3, 2025 — Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug ... 'Dancing the Blues Away' Seen in Brain ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Advanced AI genetics models reveal key genetic markers and potential drug repurposing for Parkinson's disease, accelerating ...

The Food and Drug Administration recently approved a new drug for those living with advanced Parkinson’s. Movement disorders neurologist Dr. Leon Meytin with Hartford HealthCare’s Ayer ...

The exact cause of Parkinson’s remains unclear, but scientists are investigating factors that might increase the risk, including the potential role of antiepileptic drugs. Antiepileptic drugs ...